Skip to content

Peritoneal Dialysis Registration System (PERSIST)

Peritoneal Dialysis Registration System (PERSIST)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02989298
Enrollment
10000
Registered
2016-12-12
Start date
2013-12-01
Completion date
2030-12-31
Last updated
2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorders Associated With Peritoneal Dialysis, ESRD

Keywords

Peritoneal Dialysis (PD), Residual renal function, Peritoneum function, Peritonitis rate, Technical survival, Patient survival

Brief summary

Brief Summary: The investigators are registering all PD patients at recruited hospitals and developing a PD database in China. Patients will be followed up every 3 months, and both baseline and follow-up information will be collected and input into the registration system. The patient survival, technical survival, peritonitis rate, longitudinal changes of residual renal function and peritoneum function, and quality of life for PD patients, etc, will be compared using the PD database.

Detailed description

Detailed Description: The investigators are registering all end stage renal disease (ESRD) patients receiving peritoneal dialysis (PD) treatment, and developing a PD database in China. Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking, drinking, and education, etc), clinical characteristics (primary cause of ESRD, dialysis prescription, patient's condition and lab measurements of serum, urine, and dialysate), drug information, complications and scores of quality of life at the baseline will be collected. Patients will be followed up every 3 months. Demographic and clinical characteristics, complications, drug information of patients will be collected at each visit. The patients' clinical outcomes, such as mortality (including all-cause mortality and cardiovascular disease mortality), technical survival, kidney transplantation, transfer to hemodialysis, hospitalization, occurrence of peritonitis, etc. were also followed up till the end of the study. The data of patient survival, technical survival, peritonitis rate, hospitalization rate, clinical lab parameters, longitudinal changes of residual renal function and peritoneum function, peritonitis rate, hospitalization rate, clinical lab parameters and quality of life for PD patients will be analyzed using the PD database.

Interventions

OTHERNo intervention

Registration of all PD patients in the First Affiliated Hospital of Sun Yat-sen University and other hospitals,which have signed the contract in China.

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

PD patients -

Exclusion criteria

No \-

Design outcomes

Primary

MeasureTime frameDescription
Patient survival of PD patients10 yearsPatient survival including all-cause and cardiovascular mortality.

Secondary

MeasureTime frame
Technical survival of PD patients10 years

Countries

China

Contacts

CONTACTXueqing Yu, M.D. & Ph.D.
yuxq@mail.sysu.edu.cn8620-87766335
CONTACTXiao Yang, M.D. & Ph.D.
yangxsysu@126.com8620-87755766
PRINCIPAL_INVESTIGATORXueqing Yu, M.D. & Ph.D.

First Affiliated Hospital, Sun Yat-Sen University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026